COA/ICORS2019: Effects of umbilical cord MSCs, HA and somatotropin in knee osteoarthritis treatment .
Umbilical Cord Mesenchymal Stem Cells for Treating Early Osteoarthritis of the Knee: A Randomized Controlled Trial
28 knees from 15 patients with knee osteoarthritis were randomized to receive an implantation of umbilical cord mesenchymal cell (UC-MSCs) implantation alongside hyaluronic acid injections and somatotropin injections, UC-MSC implantation with hyaluronic acid (HA) injection, or hyaluronic acid injection only. Outcomes of interest included the International Knee Documentation Committee (IKDC) score, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Visual Analog Scale (VAS), and MRI T2 mapping of knee cartilage. Follow up was performed up to 12 months post-implantation. Results revealed significant differences among the three groups in IKDC score at 12 months. The US-MSC+somatotropin group displayed a significant medial T2 improvement in knee cartilage after 12 months, and overall achieved the highest level of improvement.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
